Published Date: 02 Mar 2023
Researchers from the Barts Cancer Institute and the Francis Crick Institute at Queen Mary University of London have discovered why patients with rare blood cancers suffer from the development of poor red blood cells and...
Read Full NewsThe history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.
US radiologists vary substantially in their reading of low-dose CT lung cancer screens, highlighting a need for measures to help standardize interpretation.
Researchers compare first-line chemotherapy regimens in older patients with classical Hodgkin lymphoma to assess whether AVD is associated with better outcomes in routine care.
Researchers analyze individual patient data from five randomized phase 3 trials comparing PORT alone vs PORT plus hormone therapy in patients with recurrent prostate cancer.
A new real-world analysis helps clarify the most informative prognostic PSA benchmark in men with metastatic castration-sensitive prostate cancer.
Tissue-free ctDNA may be comparable to tumor-informed assays in detecting molecular residual disease.
1.
Radionuclide-Containing Combo Slows Metastatic Prostate Cancer, Improves Survival
2.
EHA: European Hematology Association
3.
Men over 75 years old may be significantly more likely to commit suicide if they have cancer.
4.
MCh in Gynecologic Oncology: Admission, Medical School, Fees, Qualifications Information
5.
Pancreatic cancer RNA vaccine shows durable T cell immunity
1.
The Unseen Danger of Anal Cancer: How to Protect Yourself
2.
Unlocking the Potential of Cancer Antigen 19-9 for Early Detection
3.
Clinical Pharmacology of Iron Homeostasis Regulatory Therapeutics
4.
Emerging Insights in Oncology and Quality Improvement
5.
Navigating the Complexity of Peritoneal Carcinomatosis: A Guide for Patients and Caregivers
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
2.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
4.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
5.
Hands-on Workshop: Hematology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation